FDA Inspection 1279864 — Frontida BioPharm Inc
The FDA completed an inspection of Frontida BioPharm Inc on Jul 22, 2025 in Philadelphia, PA. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Tobacco.
Inspection Details
- Classification
- No Action Indicated (NAI)
- End Date
- Jul 22, 2025
- Fiscal Year
- 2025
- Product Type
- Tobacco
- Project Area
- Tobacco Post-Market Activities
- Location
- Philadelphia, PA (United States)